MMP9 and migraine disorder: The glucocorticoid mechanisms are associated with steroidal anti-inflammatory effects or direct involvement in migraine pathophysiology, such as expression of various MMP-9 inhibitors, reduced blood-brain barrier permeability, production of nitric oxide, and reduction of the level of CGRP.